At the recent American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, researchers reported that treatment with benralizumab (Fasenra) was noninferior to mepolizumab (Nucala) for ...

Find effective medications for 'Microscopic Polyangiitis treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to ...

This page lists all known medications that could potentially lead to 'Polyangiitis' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

Please provide your email address to receive an email when new articles are posted on . Systemic corticosteroid use decreased with mepolizumab treatment. Mean daily oral corticosteroid use fell by 18% ...

New indication supported by the MANDARA trial, which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids AstraZeneca’s Fasenra (benralizumab) ...

Please provide your email address to receive an email when new articles are posted on . Patients began with mepolizumab or benralizumab before switching to continuing with benralizumab at week 52.

The FDA approved the asthma drug benralizumab (Fasenra) as a new therapy for adults with eosinophilic granulomatosis with polyangiitis (EGPA), drugmaker AstraZeneca announced on Wednesday. EGPA, ...

Granulomatosis with polyangiitis (GPA) is a rare condition where the blood vessels become inflamed GRANULOMATOSIS with polyangiitis is a serious condition that can have life-threatening consequences ...

NS-229 is currently being evaluated in a phase 2 trial in patients with eosinophilic granulomatosis with polyangiitis. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ...

Introduction: Granulomatosis with polyangiitis (GPA) is an autoimmune disease leading to necrotizing lesions in the affected tissues. Computed tomography (CT) of paranasal sinuses reveals multiple ...

Rituximab no better than glucocorticoids alone for inducing remission in patients with eosinophilic granulomatosis with polyangiitis. HealthDay News — For patients with eosinophilic granulomatosis ...